Literature DB >> 19165526

Creating a map of psychiatric patients based on psychopathological symptom profiles.

Samy Egli1, Michael Riedel, Hans-Jürgen Möller, Anton Strauss, Damian Läge.   

Abstract

BACKGROUND: In the current debate about the categorical or dimensional classification of mental disorders many fruitful methods to illustrate one or the other aspect are employed, and suggestions are made to combine the two perspectives.
METHODS: We present such an approach to combine both perspectives at the same time. Based on psychopathological AMDP-symptom profiles, a map of psychiatric patients was calculated by robust nonmetric multidimensional scaling (NMDS).
RESULTS: The sample from the Ludwig-Maximilians University in Munich included the records of patients, who were admitted and discharged in 2002 and 2003 with a diagnosis of either paranoid schizophrenia, (F20.00, N = 24), bipolar affective disorder, current episode manic without psychotic symptoms (F31.1, N = 32) or severe depressive episode without psychotic symptoms (F32.2, N = 78). In the resulting map of patients we found a clear categorical distinction according to the diagnostic groups, but also high regression values of AMDP-syndromes (manic syndrome: r = 0.83, depressive syndrome: r = 0.68, and paranoid-hallucinatory syndrome, r = 0.62). DISCUSSION: The map of psychiatric patients presents an approach to consider the categorical and dimensional aspects at the same time. We were able to identify meaningful delineations between diagnostic clusters as well as continuous transitions. This method allows the whole psychopathological profile of each individual patient to be considered and also to identify misdiagnosed cases at a glance.

Entities:  

Mesh:

Year:  2009        PMID: 19165526     DOI: 10.1007/s00406-008-0848-1

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  35 in total

1.  Conceptual validity of a phenomenological classification of psychiatric patients.

Authors:  J E Overall; J A Woodward
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Boundaries of mental disorders.

Authors:  Assen Jablensky
Journal:  Curr Opin Psychiatry       Date:  2005-11       Impact factor: 4.741

3.  Categorical versus dimensional approaches to diagnosis: methodological challenges.

Authors:  Helena Chmura Kraemer; Art Noda; Ruth O'Hara
Journal:  J Psychiatr Res       Date:  2004-01       Impact factor: 4.791

4.  Fifteen-year follow-up of ICD-10 schizoaffective disorders compared with schizophrenia and affective disorders.

Authors:  M Jäger; R Bottlender; A Strauss; H-J Möller
Journal:  Acta Psychiatr Scand       Date:  2004-01       Impact factor: 6.392

5.  Prevalence and background factors of depression in first admitted schizophrenic patients.

Authors:  R Bottlender; A Strauss; H J Möller
Journal:  Acta Psychiatr Scand       Date:  2000-02       Impact factor: 6.392

6.  A conceptual and psychometric framework for distinguishing categories and dimensions.

Authors:  Paul De Boeck; Mark Wilson; G Scott Acton
Journal:  Psychol Rev       Date:  2005-01       Impact factor: 8.934

7.  Dimensional approaches in diagnostic classification: a critical appraisal.

Authors:  Marsha F Lopez; Wilson M Compton; Bridget F Grant; James P Breiling
Journal:  Int J Methods Psychiatr Res       Date:  2007       Impact factor: 4.035

8.  The continuum/spectrum concept of mood disorders: is mixed depression the basic link?

Authors:  Franco Benazzi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-09-07       Impact factor: 5.270

9.  Assessing dimensional and categorical aspects of depression: validation of the AMDP Depression Scale.

Authors:  E Lauterbach; H-J Rumpf; B Ahrens; H-J Haug; R Schaub; H Schönell; R-D Stieglitz; F Hohagen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-12       Impact factor: 5.270

10.  Symptom profiles of psychiatric disorders based on graded disease classes: an illustration using data from the WHO International Pilot Study of Schizophrenia.

Authors:  K G Manton; A Korten; M A Woodbury; M Anker; A Jablensky
Journal:  Psychol Med       Date:  1994-02       Impact factor: 7.723

View more
  6 in total

1.  Exploring the structure of psychopathological symptoms: a re-analysis of AMDP data by robust nonmetric multidimensional scaling.

Authors:  Damian Läge; Samy Egli; Michael Riedel; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-11-08       Impact factor: 5.270

2.  Combining the categorical and the dimensional perspective in a diagnostic map of psychotic disorders.

Authors:  Damian Läge; Samy Egli; Michael Riedel; Anton Strauss; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-07-30       Impact factor: 5.270

Review 3.  [Syndromal versus nosological diagnosis].

Authors:  M Jäger; K Frasch; T Becker
Journal:  Nervenarzt       Date:  2013-09       Impact factor: 1.214

4.  DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences--part 1: general aspects and paradigmatic discussion of depressive disorders.

Authors:  Hans-Jürgen Möller; Borwin Bandelow; Michael Bauer; Harald Hampel; Sabine C Herpertz; Michael Soyka; Utako B Barnikol; Simone Lista; Emanuel Severus; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-14       Impact factor: 5.270

5.  Does psychopathology at admission predict the length of inpatient stay in psychiatry? Implications for financing psychiatric services.

Authors:  Ingeborg Warnke; Wulf Rössler; Uwe Herwig
Journal:  BMC Psychiatry       Date:  2011-07-29       Impact factor: 3.630

Review 6.  Comprehensive Psychopathological Assessment Based on the Association for Methodology and Documentation in Psychiatry (AMDP) System: Development, Methodological Foundation, Application in Clinical Routine, and Research.

Authors:  Rolf-Dieter Stieglitz; Achim Haug; Erdmann Fähndrich; Michael Rösler; Wolfgang Trabert
Journal:  Front Psychiatry       Date:  2017-04-07       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.